Table 1 Baseline characteristics of patients.
From: A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
Baseline | 48 patients | 22 under placebo | 26 under rotigotine |
|---|---|---|---|
Age | 58.8 ± 7.6 (44.6; 70.2) | 60.9 ± 8.4 (44.6; 70.2) | 57.1 ± 6.5 (45.1; 67.9) |
Disease duration (mo) | 25 ± 17.1 (0; 80) | 24 ± 18 (3; 61) | 26 ± 16.4 (0; 80) |
Sex (male) | 32 (66.7%) | 15 (68.2%) | 17 (65.4%) |
FAB | 16.7 ± 1 (15; 18) | 16.8 ± 1.1 (15; 18) | 16.6 ± 1.0 (15; 18) |
MDRS | 139.9 ± 2.9 (133; 144) | 139.6 ± 3.1 (133; 144) | 140.2 ± 2.8(133; 144) |
Rasagiline (No. of pts.) | 14 | 5 | 9 |
Antidepressant (No. of pts.) | 10 | 5 | 5 |
